Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02271386 · ClinicalTrials.gov registry record · NA
Educating and Supporting Primary Care Providers in the Implementation of Evidence-based Practices for ADHD
A NA study of Attention Deficit Hyperactivity Disorder, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- NA
- Development phase
- 895
- Enrollment target
- 1
- Study location
NCT02271386: Completed NA study of Attention Deficit Hyperactivity Disorder, sponsored by Children's Hospital of Philadelphia.
NCT02271386 is a NA study of Attention Deficit Hyperactivity Disorder that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 895 participants, above the 208-participant average among 102 other Attention Deficit Hyperactivity Disorder trials with a reported enrollment target (330% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02271386, a NA study of Attention Deficit Hyperactivity Disorder, has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- NA
- Development phase
- 895 participants
- Enrollment target
- 1
- Study location
Study Summary
Although numerous studies have demonstrated that a high percentage of primary care providers (PCPs) are knowledgeable about the American Academy of Pediatrics' guidelines for managing ADHD, many fail to implement these guidelines correctly. The goal of this project is to increase the use of evidence-based practices (EBP) for assessing and treating children with ADHD between 5 and 12 years in the context of primary care practice. This randomized controlled trial will evaluate the whether a 3-part intervention (education about ADHD management and communication training, collaborative consultation, and performance feedback regarding use of EBPs) is effective in improving EBP use among primary care providers.
Primary Outcome
This measure is based on chart review of patients of clinicians in each study arm (up to 4 patients per clinician) and reflects whether there is evidence that a parent rating scale was sent out during the baseline interval
Conditions Studied
Interventions
- BEHAVIORAL Supporting Practice for ADHD (SPA)
Study Locations (1)
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 895 participants |
| Start Date | 2014-11 |
| Est. Completion | 2016-07-31 |
| Phase | NA |
What the finished NCT02271386 record still lists
NCT02271386 is an interventional study that assigns participants to a tested intervention. The registered 895 participants enrollment target is mid-sized for trials with a published cap, above the 208-participant average among 102 other Attention Deficit Hyperactivity Disorder trials with a reported enrollment target (330% higher).
The record links to 1 condition, with Attention Deficit Hyperactivity Disorder appearing as the primary indexed condition, and to 1 intervention - of which Supporting Practice for ADHD (SPA) is the first listed.
NCT02271386 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02271386 about?
NCT02271386 is a clinical study titled "Educating and Supporting Primary Care Providers in the Implementation of Evidence-based Practices for ADHD". Although numerous studies have demonstrated that a high percentage of primary care providers (PCPs) are knowledgeable about the American Academy of Pediatrics' guidelines for managing ADHD, many fail to implement these guidelines correctly. The goal of this project is to increase the use of evidence...
What is the current status of trial NCT02271386?
This trial is currently completed. It is a NA study. The enrollment target is 895 participants. The study started on 2014-11. Estimated completion is 2016-07-31.
What conditions does trial NCT02271386 study?
This clinical trial studies the following conditions: Attention Deficit Hyperactivity Disorder.
What interventions are being tested in trial NCT02271386?
The interventions under investigation include: Supporting Practice for ADHD (SPA) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02271386?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02271386 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Attention Deficit Hyperactivity Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02271386's enrollment target sits among peer trials
895 4th of 102 higher than 99 of 102 other Attention Deficit Hyperactivity Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Attention Deficit Hyperactivity Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
HOPS Study: A Conceptual Replication
RECRUITING · NA
-
Acute Effects of Exercise in College Students With ADHD
RECRUITING · NA
-
Motor Attention Training for Attention Deficit Hyperactivity Disorder (ADHD)
RECRUITING · NA
-
ADHD PreSMA Response Inhibition Therapy
RECRUITING · NA
-
Mindfulness Intervention for College Students With ADHD
RECRUITING · NA
-
BUILT Family Lifestyle Program for Children with ADHD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04862663 · 895 participants · Phase 3
Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)
- NCT05855200 · 892 participants · Phase 3
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
- NCT02352116 · 900 participants · NA
Evaluation of Post-PACU Pain Management in Pediatric Surgery
- NCT02414347 · 900 participants
F 18 T807 Tau PET Imaging of Alzheimer's Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia